Skip to main content
Premium Trial:

Request an Annual Quote

NeuMoDx Gets CE Mark for Cytomegalovirus, Epstein-Barr Virus Tests

NEW YORK – NeuMoDx Molecular said this week that its molecular assays for cytomegalovirus (CMV) and Epstein-Barr virus have received CE-IVD marking and are now commercially available in Europe and other locations that recognize the designation.

NeuMoDx's tests are designed for central laboratory use and run on the company's fully automated NeuMoDx 96 or 288 real-time PCR systems, which provide different levels of throughput. 

Patient samples can be loaded in a continuous random-access manner, resulting in on-demand, high-throughput sample processing with an operator walkway window of up to eight hours and first test results available in about an hour, the company said.

In September, Qiagen and NeuMoDx signed a partnership and merger agreement related to the commercialization of the NeuMoDx test systems. Under the agreement, Qiagen is distributing the systems in Europe and other ex-US markets. Qiagen also owns about 20 percent of Ann Arbor, Michigan-based NeuMoDx, and has the right to acquire all remaining shares for a predetermined price of approximately $234 million, subject to the achievement of regulatory and operational milestones.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.